Full Text
The Full Text of this article is available as a PDF (250.8 KB).
letter . 1998 Jan 17;316(7126):232–233.
Severe persistent visual field constriction associated with vigabatrin. Benefit: risk ratio must be calculated for individual patients.
G F Harding
G F Harding
Find articles by G F Harding
PMCID: PMC2665458 PMID: 9468716
See the article "Severe persistent visual field constriction associated with vigabatrin." in volume 314 on page 180.